Have your own idea? Try our Stock Screener
Swiss (SMI) Biotech Industry Analysis
UpdatedMay 02, 2026
DataAggregated Company Financials
Companies4
- 7D-3.0%
- 3M-16.5%
- 1Y-11.5%
- YTD-21.5%
Over the last 7 days, the Biotech industry has dropped 6.6%, driven by a pullback from Kuros Biosciences of 4.8%. Meanwhile, Idorsia actually outperformed within the industry, gaining 6.6% in the last week. Over the last year, the industry has been flat overall. As for the next few years, earnings are expected to grow by 42% per annum.
Industry Valuation and Performance
Has the Swiss Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 02 May 2026 | CHF 1.6b | CHF 346.6m | -CHF 19,486,479.22 | 214.7x | -83.8x | 4.7x |
| Mon, 30 Mar 2026 | CHF 1.7b | CHF 349.0m | -CHF 19,444,797.56 | 225.8x | -86.4x | 4.8x |
| Wed, 25 Feb 2026 | CHF 2.0b | CHF 335.7m | -CHF 25,892,000.00 | 16.3x | -75.5x | 5.8x |
| Fri, 23 Jan 2026 | CHF 2.1b | CHF 339.6m | CHF 6.5m | 9.3x | 322.4x | 6.2x |
| Sun, 21 Dec 2025 | CHF 2.2b | CHF 339.6m | CHF 6.5m | 9x | 334.5x | 6.4x |
| Tue, 18 Nov 2025 | CHF 1.8b | CHF 343.6m | -CHF 10,514,000.00 | 7.9x | -170.5x | 5.2x |
| Thu, 16 Oct 2025 | CHF 2.0b | CHF 344.3m | -CHF 15,083,000.00 | 8.2x | -130x | 5.7x |
| Sat, 13 Sep 2025 | CHF 1.8b | CHF 383.4m | -CHF 57,057,000.00 | 7.9x | -31.8x | 4.7x |
| Mon, 11 Aug 2025 | CHF 2.0b | CHF 333.9m | -CHF 44,705,000.00 | 8.2x | -43.9x | 5.9x |
| Wed, 09 Jul 2025 | CHF 1.9b | CHF 333.9m | -CHF 44,705,000.00 | 7.5x | -42.6x | 5.7x |
| Fri, 06 Jun 2025 | CHF 1.9b | CHF 333.9m | -CHF 44,705,000.00 | 7.8x | -41.6x | 5.6x |
| Sun, 04 May 2025 | CHF 2.0b | CHF 336.6m | -CHF 39,259,000.00 | 7x | -50x | 5.8x |
| Tue, 01 Apr 2025 | CHF 1.6b | CHF 409.3m | -CHF 35,110,868.00 | 5x | -46.4x | 4x |
| Thu, 27 Feb 2025 | CHF 1.8b | CHF 387.3m | -CHF 48,828,868.00 | 5.2x | -36.5x | 4.6x |
| Sat, 25 Jan 2025 | CHF 1.7b | CHF 330.3m | -CHF 75,131,868.00 | 3x | -22.7x | 5.2x |
| Mon, 23 Dec 2024 | CHF 1.6b | CHF 330.9m | -CHF 87,805,465.00 | 2x | -18.2x | 4.8x |
| Wed, 20 Nov 2024 | CHF 1.7b | CHF 331.2m | -CHF 86,988,629.00 | 1.6x | -19.3x | 5.1x |
| Fri, 18 Oct 2024 | CHF 1.8b | CHF 333.1m | -CHF 82,023,629.00 | 1.7x | -21.6x | 5.3x |
| Sun, 15 Sep 2024 | CHF 1.6b | CHF 333.6m | -CHF 81,088,264.00 | 1.7x | -19.6x | 4.8x |
| Tue, 13 Aug 2024 | CHF 764.0m | CHF 170.7m | -CHF 141,356,264.00 | 1.9x | -5.4x | 4.5x |
| Thu, 11 Jul 2024 | CHF 762.2m | CHF 151.7m | -CHF 146,197,264.00 | 1.4x | -5.2x | 5x |
| Sat, 08 Jun 2024 | CHF 624.2m | CHF 169.6m | -CHF 138,782,703.30 | 0.8x | -4.5x | 3.7x |
| Mon, 06 May 2024 | CHF 491.2m | CHF 170.9m | -CHF 134,985,183.26 | 1x | -3.6x | 2.9x |
| Wed, 03 Apr 2024 | CHF 367.8m | CHF 67.5m | -CHF 173,150,059.04 | 0.2x | -2.1x | 5.4x |
| Fri, 01 Mar 2024 | CHF 362.2m | CHF 55.6m | -CHF 173,204,592.28 | 0.2x | -2.1x | 6.5x |
| Sun, 28 Jan 2024 | CHF 356.5m | CHF 317.6m | -CHF 175,988,325.00 | 0.8x | -2x | 1.1x |
| Tue, 26 Dec 2023 | CHF 297.6m | CHF 317.5m | -CHF 176,055,741.00 | 0.7x | -1.7x | 0.9x |
| Thu, 23 Nov 2023 | CHF 308.6m | CHF 318.2m | -CHF 210,776,884.00 | n/a | -1.5x | 1x |
| Sat, 21 Oct 2023 | CHF 255.6m | CHF 318.1m | -CHF 212,855,890.00 | n/a | -1.2x | 0.8x |
| Mon, 18 Sep 2023 | CHF 272.7m | CHF 318.0m | -CHF 219,084,709.00 | n/a | -1.2x | 0.9x |
| Wed, 16 Aug 2023 | CHF 518.2m | CHF 325.8m | -CHF 175,644,306.00 | n/a | -3x | 1.6x |
| Fri, 14 Jul 2023 | CHF 313.4m | CHF 319.2m | -CHF 179,596,254.00 | n/a | -1.7x | 1x |
| Sun, 11 Jun 2023 | CHF 326.3m | CHF 333.4m | -CHF 181,065,590.00 | n/a | -1.8x | 1x |
| Tue, 09 May 2023 | CHF 372.3m | CHF 497.2m | -CHF 18,369,594.00 | 1.7x | -20.3x | 0.7x |
Price to Earnings Ratio
-20.3x
Current Industry PE
- Investors are optimistic on the Swiss Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.2x is lower than the industry's current PS ratio of 4.9x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 11% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the Swiss Healthcare industry?
| CH Market | -0.28% | |
| Healthcare | 0.056% | |
| Biotech | -3.03% | |
| Biotech | -3.03% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BSLN Basilea Pharmaceutica | CHF 54.40 | 2.6% +CHF 17.2m | 21.3% | PE16.6x | |
| MMTX MindMaze Therapeutics Holding | CHF 0.32 | 6.6% +CHF 3.1m | n/a | n/a | |
| SANN Santhera Pharmaceuticals Holding | CHF 17.00 | 0.4% +CHF 835.6k | 15.8% | PS3.1x |